CIK 0001137883
- Non-accelerated filer
- Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 207273918
- Phone
- +1 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- 4 Open-market sale Director sold 168,000 shares at $0.30 ($50,400)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 5,000 shares at $0.30 ($1,500)
- 4 Open-market sale Director sold 104,466 shares at an average $0.30 ($31,448)
- 4 Open-market sale Director sold 27,354 shares at $0.30 ($8,206)
- 4 Open-market sale Director sold 43,630 shares at $0.30 ($13,089)
- 4 Open-market sale Director sold 40,400 shares at $0.31 ($12,322)
- 4 Open-market sale Director sold 50,000 shares at $0.31 ($15,500)
- 4 Open-market sale Director sold 131,468 shares at an average $0.32 ($41,830)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 575,000 shares at an average $0.26 ($147,098)
- 4 Open-market sale Director sold 200,000 shares at an average $0.29 ($58,290)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 13 of 17 · 329 filings